372 related articles for article (PubMed ID: 17507042)
21. Spinal effects of the fesoterodine metabolite 5-hydroxymethyl tolterodine and/or doxazosin in rats with or without partial urethral obstruction.
Füllhase C; Soler R; Gratzke C; Brodsky M; Christ GJ; Andersson KE
J Urol; 2010 Aug; 184(2):783-9. PubMed ID: 20639056
[TBL] [Abstract][Full Text] [Related]
22. Evidence of a peripheral role of neurokinins in detrusor hyperreflexia: a further study of selective tachykinin antagonists in chronic spinal injured rats.
Abdel-Gawad M; Dion SB; Elhilali MM
J Urol; 2001 May; 165(5):1739-44. PubMed ID: 11342967
[TBL] [Abstract][Full Text] [Related]
23. Improvement of bladder storage function by alpha1-blocker depends on the suppression of C-fiber afferent activity in rats.
Yokoyama O; Yusup A; Oyama N; Aoki Y; Tanase K; Matsuta Y; Miwa Y; Akino H
Neurourol Urodyn; 2006; 25(5):461-7. PubMed ID: 16673377
[TBL] [Abstract][Full Text] [Related]
24. Long-term efficacy and safety of tolterodine in children with neurogenic detrusor overactivity.
Reddy PP; Borgstein NG; Nijman RJ; Ellsworth PI
J Pediatr Urol; 2008 Dec; 4(6):428-33. PubMed ID: 19013412
[TBL] [Abstract][Full Text] [Related]
25. Effects of the selective prostacyclin receptor antagonist RO3244019 on the micturition reflex in rats.
Cefalu JS; Zhu QM; Eggers AC; Kaan TK; Ho MJ; Jett MF; Cockayne DA; Ford AP; Nunn PA
J Urol; 2007 Dec; 178(6):2683-8. PubMed ID: 17945281
[TBL] [Abstract][Full Text] [Related]
26. Selective pharmacological blockade of the TRPV1 receptor suppresses sensory reflexes of the rodent bladder.
Cefalu JS; Guillon MA; Burbach LR; Zhu QM; Hu DQ; Ho MJ; Ford AP; Nunn PA; Cockayne DA
J Urol; 2009 Aug; 182(2):776-85. PubMed ID: 19539322
[TBL] [Abstract][Full Text] [Related]
27. Cold environmental stress induces detrusor overactivity via resiniferatoxin-sensitive nerves in conscious rats.
Imamura T; Ishizuka O; Aizawa N; Zhong C; Ogawa T; Nakayama T; Tanabe T; Nishizawa O
Neurourol Urodyn; 2008; 27(4):348-52. PubMed ID: 17701982
[TBL] [Abstract][Full Text] [Related]
28. Urodynamic effects of a novel EP(1) receptor antagonist in normal rats and rats with bladder outlet obstruction.
Lee T; Hedlund P; Newgreen D; Andersson KE
J Urol; 2007 Apr; 177(4):1562-7. PubMed ID: 17382779
[TBL] [Abstract][Full Text] [Related]
29. Antimuscarinic effects on current perception threshold: a prospective placebo control study.
Vijaya G; Digesu GA; Derpapas A; Hendricken C; Fernando R; Khullar V
Neurourol Urodyn; 2012 Jan; 31(1):75-9. PubMed ID: 22038939
[TBL] [Abstract][Full Text] [Related]
30. Effects of resiniferatoxin desensitization of capsaicin-sensitive afferents on detrusor over-activity induced by intravesical capsaicin, acetic acid or ATP in conscious rats.
Zhang X; Igawa Y; Ishizuka O; Nishizawa O; Andersson KE
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):473-9. PubMed ID: 12700886
[TBL] [Abstract][Full Text] [Related]
31. Effects of ritobegron (KUC-7483), a novel β3-adrenoceptor agonist, on both rat bladder function following partial bladder outlet obstruction and on rat salivary secretion: a comparison with the effects of tolterodine.
Maruyama I; Yonekubo S; Tatemichi S; Maruyama K; Hoyano Y; Yamazaki Y; Kusama H
J Smooth Muscle Res; 2012; 48(5-6):115-24. PubMed ID: 23538508
[TBL] [Abstract][Full Text] [Related]
32. Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
Oki T; Maruyama S; Takagi Y; Yamamura HI; Yamada S
Eur J Pharmacol; 2006 Jan; 529(1-3):157-63. PubMed ID: 16316647
[TBL] [Abstract][Full Text] [Related]
33. Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders.
Dinis P; Charrua A; Avelino A; Cruz F
BJU Int; 2004 Jul; 94(1):153-7. PubMed ID: 15217452
[TBL] [Abstract][Full Text] [Related]
34. Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
Abrams P; Kaplan S; De Koning Gans HJ; Millard R
J Urol; 2006 Mar; 175(3 Pt 1):999-1004; discussion 1004. PubMed ID: 16469601
[TBL] [Abstract][Full Text] [Related]
35. The role of bladder afferent pathways in bladder hyperactivity induced by the intravesical administration of nerve growth factor.
Chuang YC; Fraser MO; Yu Y; Chancellor MB; de Groat WC; Yoshimura N
J Urol; 2001 Mar; 165(3):975-9. PubMed ID: 11176525
[TBL] [Abstract][Full Text] [Related]
36. Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity.
Giannitsas K; Perimenis P; Athanasopoulos A; Gyftopoulos K; Nikiforidis G; Barbalias G
Eur Urol; 2004 Dec; 46(6):776-82; discussion 782-3. PubMed ID: 15548447
[TBL] [Abstract][Full Text] [Related]
37. Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
Serati M; Salvatore S; Uccella S; Cardozo L; Bolis P
Eur Urol; 2009 Mar; 55(3):713-9. PubMed ID: 18584946
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological effects of propiverine and its active metabolite, M-1, on isolated human urinary bladder smooth muscle, and on bladder contraction in rats.
Sugiyama Y; Yoshida M; Masunaga K; Satoji Y; Maeda Y; Nagata T; Inadome A; Ueda S
Int J Urol; 2008 Jan; 15(1):76-81. PubMed ID: 18184179
[TBL] [Abstract][Full Text] [Related]
39. Effects of goshajinkigan (niu-che-sen-qi-wan) for resiniferatoxin-sensitive afferents on detrusor overactivity induced by acetic acid in conscious rats.
Zhang X; Ishizuka O; Tanabe T; Satoh T; Nakayama T; Imamura T; Nishizawa O
Am J Chin Med; 2006; 34(2):285-93. PubMed ID: 16552839
[TBL] [Abstract][Full Text] [Related]
40. Effect of long-term oxybutynin administration on c-Fos expression in spinal neurons: inhibition of antimuscarinics on bladder afferents in conscious rats.
Haga N; Aikawa K; Shishido K; Takahashi N; Yanagida T; Yamaguchi O
Urology; 2009 Jan; 73(1):200-4. PubMed ID: 18561989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
